fda drug shortages semaglutide injection shortage resolved 2025 National Hispanic Medical Association | The federal government is stepping up to stop counterfeit weight-loss drugs. In 2025, bipartisan lawmakers urged stronger enforcement Drug shortages in 2024 reach

Semaglutide, a medication used for weight management and type 2 diabetes, is associated with various side effects

June 2024 Update: The latest docket report from the Judicial Panel on Multidistrict Litigation (JPML) indicates that there are currently 101 lawsuits filed against the manufacturers of Ozempic and other GLP-1 agonist drugs in the Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation

Signs of an allergic reaction: hives, blistering, swelling of the mouth, face, lips tongue throat, trouble breathing

Introduction Many patients notice changes in hair health during weight loss and begin to ask if GLP-1 medications are the cause